Tumor Microenvironment‐Activated Fe 3+ ‐Doped Dendritic Mesoporous Organosilica Nanocomposites as Ferroptosis Inducers for Enhanced Immunotherapy
Advanced Materials · 2025
DOI: 10.1002/adma.202510010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2025. Verfasst von Lili Feng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Superlight Materials and Surface Technology, Ministry of Education, College of Materials Science and Chemical Engineering, Harbin E…. Hauptthemen laut MEDLINE: Ferroptosis, Nanocomposites, Tumor Microenvironment, Immunotherapy. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Youth Talent Program, Heilongjiang Natural Science Foundation Project of Outstanding Youth Project, Postdoctoral Fellowship Program (Grade C) of China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Dendritic mesoporous organosilica (DMOS) nanoparticles are widely used to transport therapeutic agents to cancer sites and rapidly release them owing to their rapid biodegradability in the tumor microenvironment (TME). However, the role of these DMOS nanoparticles as nanocarriers is limited, and their applications remain relatively simple. In this study, Fe 3+ ‐doped dendritic mesoporous organosilica (Fe‐DMOS) nanoparticles are designed as a new type of ferroptosis inducer and are combined with sodium hyaluronate‐modified calcium peroxide to form TME‐responsive nanocomposites. The nanocomposites can effectively generate a large number of hydroxyl radicals through the Fenton reaction between the released Fe 3+ and self‐compensated hydrogen peroxide, and mitochondrial injury caused by Ca 2+ overload further promotes this process. Both Fe 3+ and disulfide bonds can induce glutathione depletion, thus downregulating the expression of glutathione peroxidase 4 and triggering lethal levels of lipid peroxidation products, further facilitating ferroptosis in tumor cells. Additionally, the ferroptosis‐mediated process of immunogenic cell death promotes a long‐term antitumor immune response to prevent metastasis of tumor cells with the assistance of an immune checkpoint inhibitor (anti‐PD‐1). Fe‐DMOS nanoparticles are synthesized with ferroptosis‐inducing capabilities and established TME‐responsive nanocomposites combined with an immune checkpoint inhibitor to effectively improve tumor immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Superlight Materials and Surface Technology, Ministry of Education, College of Materials Science and Chemical Engineering, Harbin Engineering University, Harbin, 150001, P. R. China.
- Cancer Institute, Affiliated Tumor Hospital of Nantong University, Nantong, 226631, P. R. China.
ORCID-Profile: Piaoping Yang
Förderung
- National Natural Science Foundation of China
- National Youth Talent Program, Heilongjiang Natural Science Foundation Project of Outstanding Youth Project
- Postdoctoral Fellowship Program (Grade C) of China Postdoctoral Science Foundation
- Heilongjiang Postdoctoral Fund
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Feng, L., Sang, J., Zhu, H., Hu, Y., Liu, B., He, G., Yang, L., Yu, C., Zhu, Y., & Yang, P. (2025). Tumor Microenvironment‐Activated Fe 3+ ‐Doped Dendritic Mesoporous Organosilica Nanocomposites as Ferroptosis Inducers for Enhanced Immunotherapy. Advanced Materials. https://doi.org/10.1002/adma.202510010
Vancouver
Feng L, Sang J, Zhu H, Hu Y, Liu B, He G, et al. Tumor Microenvironment‐Activated Fe 3+ ‐Doped Dendritic Mesoporous Organosilica Nanocomposites as Ferroptosis Inducers for Enhanced Immunotherapy. Advanced Materials. 2025. doi:10.1002/adma.202510010
BibTeX
@article{Feng2025,
author = {Feng, Lili and Sang, Jiaxu and Zhu, Haixia and Hu, Yaoyu and Liu, Bin and He, Guanting and Yang, Lu and Yu, Chenghao and Zhu, Yanlin and Yang, Piaoping},
title = {Tumor Microenvironment‐Activated Fe 3+ ‐Doped Dendritic Mesoporous Organosilica Nanocomposites as Ferroptosis Inducers for Enhanced Immunotherapy},
journal = {Advanced Materials},
year = {2025},
doi = {10.1002/adma.202510010}
}
EUVIMED